Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Mitophagy: mitofusin recruits a mitochondrial killer.

Pallanck L.

Curr Biol. 2013 Jul 8;23(13):R570-2. doi: 10.1016/j.cub.2013.05.032.

2.

VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations.

Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A, Smith RB, Ritson GP, Winborn BJ, Moore J, Lee JY, Yao TP, Pallanck L, Kundu M, Taylor JP.

Neuron. 2013 Apr 10;78(1):65-80. doi: 10.1016/j.neuron.2013.02.029. Epub 2013 Mar 14. Erratum in: Neuron. 2013 Apr 24;78(2):403.

3.

Topograph, a software platform for precursor enrichment corrected global protein turnover measurements.

Hsieh EJ, Shulman NJ, Dai DF, Vincow ES, Karunadharma PP, Pallanck L, Rabinovitch PS, MacCoss MJ.

Mol Cell Proteomics. 2012 Nov;11(11):1468-74. doi: 10.1074/mcp.O112.017699. Epub 2012 Aug 3.

4.

Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants.

Burman JL, Yu S, Poole AC, Decal RB, Pallanck L.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10438-43. doi: 10.1073/pnas.1120688109. Epub 2012 Jun 12.

5.

Neurons at the extremes of cell biology.

Heiman MG, Pallanck L.

Mol Biol Cell. 2011 Mar 15;22(6):721. doi: 10.1091/mbc.E10-12-0965. No abstract available.

6.

Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism.

Trinh K, Andrews L, Krause J, Hanak T, Lee D, Gelb M, Pallanck L.

J Neurosci. 2010 Apr 21;30(16):5525-32. doi: 10.1523/JNEUROSCI.4777-09.2010.

7.

The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway.

Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L.

PLoS One. 2010 Apr 7;5(4):e10054. doi: 10.1371/journal.pone.0010054.

8.

Neurodegenerative disease: pink, parkin and the brain.

Pallanck L, Greenamyre JT.

Nature. 2006 Jun 29;441(7097):1058. No abstract available.

PMID:
16810237
9.
10.

A tale of two C2 domains.

Pallanck L.

Trends Neurosci. 2003 Jan;26(1):2-4. Review. No abstract available.

PMID:
12495852
13.

Mechanisms of neurotransmitter release.

Littleton JT, Pallanck L, Ganetzky B.

Int Rev Neurobiol. 1999;43:139-61. Review. No abstract available.

PMID:
10218158
15.

Distinct roles for N-ethylmaleimide-sensitive fusion protein (NSF) suggested by the identification of a second Drosophila NSF homolog.

Pallanck L, Ordway RW, Ramaswami M, Chi WY, Krishnan KS, Ganetzky B.

J Biol Chem. 1995 Aug 11;270(32):18742-4.

16.

A Drosophila NSF mutant.

Pallanck L, Ordway RW, Ganetzky B.

Nature. 1995 Jul 6;376(6535):25. No abstract available.

PMID:
7596428
17.

Functional role of the beta subunit of high conductance calcium-activated potassium channels.

McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, Leonard RJ.

Neuron. 1995 Mar;14(3):645-50.

18.

New potassium channel gene families in flies and mammals: from mutants to molecules.

Ganetzky B, Warmke JW, Robertson G, Pallanck L.

Soc Gen Physiol Ser. 1995;50:29-39. Review. No abstract available.

PMID:
7676322
19.

A TPR domain in the SNAP secretory proteins.

Ordway RW, Pallanck L, Ganetzky B.

Trends Biochem Sci. 1994 Dec;19(12):530-1. No abstract available.

PMID:
7846761
20.

Supplemental Content

Loading ...
Support Center